EvlaBio
FranceEntry
2025
Hold
1yr
Status
Active
Who owns EvlaBio?
EvlaBio is a French Biotech company, currently owned by Boehringer Ingelheim Venture Fund since 2025 and 2 other investors.
Hand-verified · updated 2026-04-21
Open JSON · CC-BY
Most recent investor
High-Tech Gruenderfonds (HTGF)HTGF IV · 2022 · VC
3 ownership periods · full history below
Key facts
HQFrance
SectorBiotech
Ownership history
3 ownership periods · co-invest detected
Active
Co-held by Boehringer Ingelheim Venture Fund, AdBio Partners and High-Tech Gruenderfonds (HTGF) since 2025.
Co-invest · 3 holders · 2025 · present
AdBio PartnersActive
2025 · present(1yr) · AFB Fund II · 2021 · VC
More from HTGF IV
Other portfolio companies in the same fund.
Switzerland
Germany
Denmark
UKMore PE-backed in Biotech
Comparable biotech deals from other GPs.
USQuestions
Who owns EvlaBio?
EvlaBio is currently owned by Boehringer Ingelheim Venture Fund, AdBio Partners and 1 other, through HTGF IV, since 2025.
When did Boehringer Ingelheim Venture Fund and 2 others acquire EvlaBio?
Boehringer Ingelheim Venture Fund and 2 others acquired EvlaBio in 2025.
Who has owned EvlaBio over time?
EvlaBio has been through 3 private-equity ownership periods: Boehringer Ingelheim Venture Fund · via Boehringer Ingelheim Venture Fund · since 2025; AdBio Partners · via AFB Fund II · since 2025; High-Tech Gruenderfonds (HTGF) · via HTGF IV · since 2025.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue